GO:0006304 | DNA modification | 10.31% (10/97) | 3.96 | 0.0 | 0.0 |
GO:0044728 | DNA methylation or demethylation | 10.31% (10/97) | 3.96 | 0.0 | 0.0 |
GO:0006305 | DNA alkylation | 10.31% (10/97) | 3.98 | 0.0 | 0.0 |
GO:0006306 | DNA methylation | 10.31% (10/97) | 3.98 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 27.84% (27/97) | 1.93 | 0.0 | 1e-06 |
GO:0043414 | macromolecule methylation | 13.4% (13/97) | 2.84 | 0.0 | 3e-06 |
GO:0032259 | methylation | 13.4% (13/97) | 2.84 | 0.0 | 3e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 28.87% (28/97) | 1.59 | 0.0 | 6e-06 |
GO:0016070 | RNA metabolic process | 19.59% (19/97) | 1.95 | 0.0 | 2.7e-05 |
GO:0006259 | DNA metabolic process | 14.43% (14/97) | 2.41 | 0.0 | 2.7e-05 |
GO:0006396 | RNA processing | 14.43% (14/97) | 2.34 | 1e-06 | 4.2e-05 |
GO:0046483 | heterocycle metabolic process | 28.87% (28/97) | 1.39 | 1e-06 | 7.4e-05 |
GO:0016458 | gene silencing | 9.28% (9/97) | 3.06 | 1e-06 | 7.6e-05 |
GO:0034641 | cellular nitrogen compound metabolic process | 28.87% (28/97) | 1.3 | 4e-06 | 0.000199 |
GO:0080188 | RNA-directed DNA methylation | 3.09% (3/97) | 6.4 | 5e-06 | 0.000242 |
GO:0006725 | cellular aromatic compound metabolic process | 28.87% (28/97) | 1.25 | 8e-06 | 0.000359 |
GO:0005634 | nucleus | 55.67% (54/97) | 0.71 | 9e-06 | 0.000383 |
GO:0030422 | production of siRNA involved in RNA interference | 6.19% (6/97) | 3.6 | 1.1e-05 | 0.00043 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 6.19% (6/97) | 3.57 | 1.2e-05 | 0.000437 |
GO:0031050 | dsRNA fragmentation | 6.19% (6/97) | 3.57 | 1.2e-05 | 0.000437 |
GO:0051607 | defense response to virus | 6.19% (6/97) | 3.51 | 1.5e-05 | 0.000526 |
GO:0031047 | gene silencing by RNA | 7.22% (7/97) | 3.13 | 1.6e-05 | 0.000529 |
GO:0044424 | intracellular part | 89.69% (87/97) | 0.32 | 1.7e-05 | 0.000535 |
GO:1901360 | organic cyclic compound metabolic process | 28.87% (28/97) | 1.18 | 2e-05 | 0.000583 |
GO:0052018 | modulation by symbiont of RNA levels in host | 5.15% (5/97) | 3.82 | 2.9e-05 | 0.000742 |
GO:0052249 | modulation of RNA levels in other organism involved in symbiotic interaction | 5.15% (5/97) | 3.82 | 2.9e-05 | 0.000742 |
GO:0009616 | virus induced gene silencing | 5.15% (5/97) | 3.82 | 2.9e-05 | 0.000742 |
GO:0098586 | cellular response to virus | 5.15% (5/97) | 3.8 | 3e-05 | 0.000751 |
GO:0010629 | negative regulation of gene expression | 10.31% (10/97) | 2.35 | 2.8e-05 | 0.000789 |
GO:0035821 | modification of morphology or physiology of other organism | 5.15% (5/97) | 3.68 | 4.6e-05 | 0.000966 |
GO:0044003 | modification by symbiont of host morphology or physiology | 5.15% (5/97) | 3.68 | 4.6e-05 | 0.000966 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 5.15% (5/97) | 3.68 | 4.6e-05 | 0.000966 |
GO:0009615 | response to virus | 6.19% (6/97) | 3.25 | 4.2e-05 | 0.001002 |
GO:0043170 | macromolecule metabolic process | 34.02% (33/97) | 0.99 | 4.5e-05 | 0.001033 |
GO:0051701 | interaction with host | 5.15% (5/97) | 3.57 | 6.7e-05 | 0.001365 |
GO:0016571 | histone methylation | 7.22% (7/97) | 2.8 | 6.9e-05 | 0.001382 |
GO:0006479 | protein methylation | 7.22% (7/97) | 2.78 | 7.4e-05 | 0.001398 |
GO:0008213 | protein alkylation | 7.22% (7/97) | 2.78 | 7.4e-05 | 0.001398 |
GO:0010605 | negative regulation of macromolecule metabolic process | 10.31% (10/97) | 2.17 | 7.8e-05 | 0.001425 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 5.15% (5/97) | 3.46 | 9.4e-05 | 0.001534 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3.09% (3/97) | 5.08 | 9.4e-05 | 0.00156 |
GO:0030880 | RNA polymerase complex | 3.09% (3/97) | 5.08 | 9.4e-05 | 0.00156 |
GO:0000428 | DNA-directed RNA polymerase complex | 3.09% (3/97) | 5.08 | 9.4e-05 | 0.00156 |
GO:0043412 | macromolecule modification | 19.59% (19/97) | 1.39 | 8.7e-05 | 0.001565 |
GO:0044419 | interspecies interaction between organisms | 5.15% (5/97) | 3.44 | 0.000101 | 0.001614 |
GO:0006325 | chromatin organization | 9.28% (9/97) | 2.27 | 0.000108 | 0.001679 |
GO:0009892 | negative regulation of metabolic process | 10.31% (10/97) | 2.11 | 0.000113 | 0.001714 |
GO:0034968 | histone lysine methylation | 6.19% (6/97) | 2.88 | 0.000172 | 0.002565 |
GO:0018022 | peptidyl-lysine methylation | 6.19% (6/97) | 2.87 | 0.000176 | 0.002573 |
GO:0016570 | histone modification | 7.22% (7/97) | 2.5 | 0.000252 | 0.003607 |
GO:0043231 | intracellular membrane-bounded organelle | 78.35% (76/97) | 0.35 | 0.000293 | 0.004113 |
GO:0043227 | membrane-bounded organelle | 78.35% (76/97) | 0.35 | 0.000315 | 0.004331 |
GO:0043687 | post-translational protein modification | 4.12% (4/97) | 3.56 | 0.000383 | 0.005174 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 3.09% (3/97) | 4.33 | 0.000448 | 0.005722 |
GO:0008380 | RNA splicing | 6.19% (6/97) | 2.63 | 0.000439 | 0.005816 |
GO:0002252 | immune effector process | 6.19% (6/97) | 2.62 | 0.000447 | 0.005822 |
GO:0040029 | regulation of gene expression, epigenetic | 6.19% (6/97) | 2.61 | 0.000474 | 0.005948 |
GO:0043226 | organelle | 78.35% (76/97) | 0.33 | 0.000507 | 0.006157 |
GO:0043229 | intracellular organelle | 78.35% (76/97) | 0.33 | 0.0005 | 0.006168 |
GO:0016569 | covalent chromatin modification | 7.22% (7/97) | 2.31 | 0.000544 | 0.006383 |
GO:0006807 | nitrogen compound metabolic process | 34.02% (33/97) | 0.8 | 0.000554 | 0.006396 |
GO:0044464 | cell part | 91.75% (89/97) | 0.22 | 0.000543 | 0.006477 |
GO:0044260 | cellular macromolecule metabolic process | 25.77% (25/97) | 0.96 | 0.000673 | 0.007524 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 4.12% (4/97) | 3.35 | 0.000663 | 0.007537 |
GO:0006312 | mitotic recombination | 3.09% (3/97) | 3.89 | 0.001098 | 0.011908 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 3.09% (3/97) | 3.89 | 0.001098 | 0.011908 |
GO:0018205 | peptidyl-lysine modification | 6.19% (6/97) | 2.32 | 0.001343 | 0.014357 |
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 4.12% (4/97) | 3.0 | 0.001611 | 0.014984 |
GO:0004386 | helicase activity | 4.12% (4/97) | 3.02 | 0.001529 | 0.014998 |
GO:0034062 | 5'-3' RNA polymerase activity | 3.09% (3/97) | 3.75 | 0.001467 | 0.015005 |
GO:0097747 | RNA polymerase activity | 3.09% (3/97) | 3.75 | 0.001467 | 0.015005 |
GO:0009560 | embryo sac egg cell differentiation | 4.12% (4/97) | 3.03 | 0.001489 | 0.015017 |
GO:0006342 | chromatin silencing | 5.15% (5/97) | 2.59 | 0.001515 | 0.015064 |
GO:0010050 | vegetative phase change | 3.09% (3/97) | 3.7 | 0.001605 | 0.015125 |
GO:0016779 | nucleotidyltransferase activity | 4.12% (4/97) | 2.99 | 0.001654 | 0.01518 |
GO:0005665 | RNA polymerase II, core complex | 2.06% (2/97) | 5.14 | 0.001443 | 0.015194 |
GO:0140098 | catalytic activity, acting on RNA | 5.15% (5/97) | 2.57 | 0.001572 | 0.015213 |
GO:0045814 | negative regulation of gene expression, epigenetic | 5.15% (5/97) | 2.57 | 0.001602 | 0.015289 |
GO:0006260 | DNA replication | 5.15% (5/97) | 2.46 | 0.002238 | 0.019783 |
GO:0006464 | cellular protein modification process | 14.43% (14/97) | 1.24 | 0.002229 | 0.01995 |
GO:0036211 | protein modification process | 14.43% (14/97) | 1.24 | 0.002229 | 0.01995 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.19% (6/97) | 2.14 | 0.002444 | 0.020833 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 6.19% (6/97) | 2.14 | 0.002444 | 0.020833 |
GO:1902679 | negative regulation of RNA biosynthetic process | 6.19% (6/97) | 2.14 | 0.002444 | 0.020833 |
GO:0008283 | cell proliferation | 4.12% (4/97) | 2.82 | 0.002552 | 0.021497 |
GO:0051253 | negative regulation of RNA metabolic process | 6.19% (6/97) | 2.12 | 0.00264 | 0.021976 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6.19% (6/97) | 2.09 | 0.002955 | 0.024041 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 6.19% (6/97) | 2.09 | 0.002955 | 0.024041 |
GO:0018193 | peptidyl-amino acid modification | 6.19% (6/97) | 2.08 | 0.003029 | 0.024364 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6.19% (6/97) | 2.08 | 0.003066 | 0.024391 |
GO:0048519 | negative regulation of biological process | 11.34% (11/97) | 1.39 | 0.003193 | 0.025125 |
GO:1990817 | RNA adenylyltransferase activity | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0043764 | UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase activity | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0080157 | regulation of plant-type cell wall organization or biogenesis | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0005666 | RNA polymerase III complex | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0004810 | tRNA adenylyltransferase activity | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0009304 | tRNA transcription | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0010521 | telomerase inhibitor activity | 1.03% (1/97) | 8.14 | 0.003542 | 0.025364 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6.19% (6/97) | 2.05 | 0.003337 | 0.025972 |
GO:0051567 | histone H3-K9 methylation | 4.12% (4/97) | 2.67 | 0.003739 | 0.026249 |
GO:0061647 | histone H3-K9 modification | 4.12% (4/97) | 2.67 | 0.003739 | 0.026249 |
GO:0005732 | small nucleolar ribonucleoprotein complex | 2.06% (2/97) | 4.44 | 0.003819 | 0.026548 |
GO:0009890 | negative regulation of biosynthetic process | 6.19% (6/97) | 2.04 | 0.0035 | 0.026947 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 4.12% (4/97) | 2.59 | 0.004454 | 0.030663 |
GO:0009086 | methionine biosynthetic process | 3.09% (3/97) | 3.13 | 0.004995 | 0.034058 |
GO:0008033 | tRNA processing | 2.06% (2/97) | 4.19 | 0.005402 | 0.036486 |
GO:0016444 | somatic cell DNA recombination | 2.06% (2/97) | 4.14 | 0.005748 | 0.03811 |
GO:0006555 | methionine metabolic process | 3.09% (3/97) | 3.05 | 0.005743 | 0.038429 |
GO:0007267 | cell-cell signaling | 3.09% (3/97) | 3.01 | 0.006222 | 0.040874 |
GO:0023052 | signaling | 3.09% (3/97) | 3.0 | 0.006387 | 0.041577 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 6.19% (6/97) | 1.85 | 0.006585 | 0.042474 |
GO:0045132 | meiotic chromosome segregation | 3.09% (3/97) | 2.96 | 0.006898 | 0.043708 |
GO:0006399 | tRNA metabolic process | 3.09% (3/97) | 2.96 | 0.006898 | 0.043708 |
GO:0098813 | nuclear chromosome segregation | 3.09% (3/97) | 2.94 | 0.007073 | 0.04404 |
GO:0003938 | IMP dehydrogenase activity | 1.03% (1/97) | 7.14 | 0.007073 | 0.04442 |
GO:0004683 | calmodulin-dependent protein kinase activity | 2.06% (2/97) | 3.97 | 0.007235 | 0.044656 |
GO:0031048 | chromatin silencing by small RNA | 3.09% (3/97) | 2.89 | 0.007802 | 0.047744 |
GO:0009067 | aspartate family amino acid biosynthetic process | 3.09% (3/97) | 2.88 | 0.00799 | 0.048076 |
GO:0031324 | negative regulation of cellular metabolic process | 6.19% (6/97) | 1.79 | 0.007929 | 0.048112 |